These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24576034)

  • 1. Five important advances in hematopathology.
    Shi M; Xiao R; Woda BA; Yu H
    Arch Pathol Lab Med; 2014 Mar; 138(3):410-9. PubMed ID: 24576034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic biomarkers in myeloid malignancies.
    Matynia AP; Szankasi P; Shen W; Kelley TW
    Arch Pathol Lab Med; 2015 May; 139(5):594-601. PubMed ID: 25152312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias).
    Hasserjian RP; Kelley TW; Weinberg OK; Morgan EA; Fend F
    Am J Clin Pathol; 2019 Aug; 152(3):302-321. PubMed ID: 31263893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation.
    Juopperi TA; Bienzle D; Bernreuter DC; Vernau W; Thrall MA; McManus PM
    Vet Pathol; 2011 Jan; 48(1):182-97. PubMed ID: 21139142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic molecular pathology of lymphatic and myeloid neoplasms].
    Klapper W; Kreipe H
    Pathologe; 2015 Mar; 36(2):164-70. PubMed ID: 25809654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
    Bock O
    Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current pathology practices in and barriers to MDS diagnosis.
    Glauser TA; Sagatys EM; Williamson JC; Burton BS; Berger C; Merwin P; Sugrue M; Bennett JM
    Leuk Res; 2013 Dec; 37(12):1656-61. PubMed ID: 24220584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis.
    Kremer M; Horn T; Dechow T; Tzankov A; Quintanilla-Martínez L; Fend F
    Leukemia; 2006 Jul; 20(7):1315-6. PubMed ID: 16617316
    [No Abstract]   [Full Text] [Related]  

  • 10. Focus on myeloproliferative diseases and myelodysplastic syndromes.
    Van Etten RA; Shannon KM
    Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?
    Verhoef GE; Demuynck H; Zachee P; Boogaerts MA
    Leukemia; 1994 Apr; 8(4):714-5. PubMed ID: 8152271
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Kremer M et al., the JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis.
    Ohyashiki K; Ohyashiki JH
    Leukemia; 2006 Jul; 20(7):1297-8. PubMed ID: 16617315
    [No Abstract]   [Full Text] [Related]  

  • 13. New molecular insights in myelodysplastic and myeloproliferative disorders.
    Emanuel PD
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):459-60. PubMed ID: 16167021
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathology consultation on intermediate-to-large B-cell lymphomas.
    Montgomery ND; Fedoriw Y
    Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia.
    Wood BL
    Clin Lab Med; 2007 Sep; 27(3):551-75, vii. PubMed ID: 17658407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of molecular haematology: flow cytometry in leukaemias and myelodysplastic syndromes.
    Dalal BI
    J Assoc Physicians India; 2007 Aug; 55():571-3. PubMed ID: 18019799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
    Machherndl-Spandl S; Sega W; Bösmüller H; Germing U; Gruber Ch; Nachtkamp K; Reinecke P; Sperr WR; Wimazal F; Müllauer L; Sotlar K; Horny HP; Tüchler H; Valent P; Krieger O
    Ann Hematol; 2014 Jan; 93(1):57-64. PubMed ID: 24241126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1509-27. PubMed ID: 3551435
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
    So CC; Ma ES; Wan TS; Yip SF; Chan LC
    Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
    [No Abstract]   [Full Text] [Related]  

  • 20. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.